Company performance
Add to research
Current Price
as of Mar 12, 2025$1.22
P/E Ratio
N/A
Market Cap
$6.32M
- DRMA
Description
Add to research
Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerDRMA
- Price$1.22-0.81%
Trading Information
- Market cap$6.32M
- Float73.47%
- Average Daily Volume (1m)192,293
- Average Daily Volume (3m)381,538
- EPS-$21.42
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$3.17M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$3.23M
- EV-$3.59M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.43
- Debt/EquityN/A
Documents
Add to research
SEC Filings